CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE

European Journal of Immunology

Volumn 37, Issue 7, 2007, Pages 2032-2042

  Yang, Yuhong ^a,b   Ratts, Robert B ^b   Hussain, Rehana Z ^b   Northrop, Sara C ^b   Ben, Li Hong ^b   Lovett Racke, Amy ^a,b   Racke, Michael K ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Costimulation; EAE MS; T cell; Vaccination

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VACCINATION;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; AUTOIMMUNITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MICE; MICE, TRANSGENIC; TH1 CELLS; TH2 CELLS; VACCINATION;

EID: 34447521710     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636971     Document Type: Article

References (39)

1. Sospedra, M. and Martin, R., Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005. 23: 683-747.
2. Martin, R., McFarland, H. F. and McFarlin, D. E., Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 1992. 10: 153-187.
3. Arredondo, L. R., Lovett-Racke, A. and Racke, M. K., Experimental autoimmune encephalomyelitis.In Herndon, R. M. (Ed.) Multiple Sclerosis: Immunology, Pathology, and Pathophysiology. Demos Medical Publishing., New York 2003. pp79-104.
4. Ben-Nun, A., Wekerle, H. and Cohen, I. R., Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981. 292: 60-61.
5. Holoshitz, J., Naparstek, Y., Ben-Nun, A. and Cohen, I. R., Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983. 219: 56-58
6. Ben-Yehuda, A., Bar-Tana, R., Livoff, A., Ron, N., Cohen, I. R. and Naparstek, Y., Lymph node cell vaccination against the lupus syndrome of MRL/lpr/lpr mice. Lupus 1996. 5: 232-236.
7. Elias, D., Tikochinski, Y., Frankel, G. and Cohen, I. R., Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide. Int. Immunol. 1999. 11: 957-966.
8. Hafler, D. A., Cohen, I., Benjamin, D. S. and Weiner, H. L., T cell vaccination in multiple sclerosis: a preliminary report. Clin. Immunol. Immunopathol. 1992. 62: 307-313.
9. Zhang, J., Medaer, R., Stinissen, P., Hafler, D. and Raus, J., MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 1993. 261: 1451-1454.
10. Medaer, R., Stinissen, P., Truyen, L., Raus, J. and Zhang, J., Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis. Lancet 1995. 346: 807-808.
11. Correale, J., Lund, B., McMillan, M., Ko, D. Y., McCarthy, K. and Weiner, L. P., T cell vaccination in secondary progressive multiple sclerosis. J. Neuroimmunol. 2000. 107: 130-139.
12. Zhang, J. Z., Rivera, V. M., Tejada-Simon, M. V., Yang, D., Hong, J., Li, S., Haykal, H. et al., T cell vaccination in multiple sclerosis: results of a preliminary study. J. Neurol. 2002. 249: 212-218.
13. Van der Aa, A., Hellings, N., Medaer, R., Gelin, G., Palmers, Y., Raus, J. and Stinissen, P., T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. Clin. Exp. Immunol. 2003. 131: 155-168.
14. Bird, L., In the news: T-cell vaccine for MS. Nat. Rev. Immunol. 2006. 6: 258.
15. Lider, O., Reshef, T., Beraud, E., Ben-Nun, A. and Cohen, I. R., Anti-idiorypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988. 239: 181-183.
16. Lohse, A. W., Mor, F., Karin, N. and Cohen, I. R., Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989. 244: 820-822.
17. Jiang, H., Kashleva, H., Xu, L. X., Forman, J., Flaherty, L., Pernis, B., Braunstein, N. S. and Chess, L., T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sci. USA 1998. 95: 4533-4537.
18. Panoutsakopoulou, V., Huster, K. M., McCarty, N., Feinberg, E., Wang, R., Wucherpfennig, K. W. and Cantor, H., Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J. Clin. Invest. 2004. 113: 1218-1224.
19. + T cells in EAE mice. Proc. Natl. Acad. Sci. USA 2001. 98: 6301-6306.
20. Gay, R W., Drye, T. J., Dick, G. W. and Esiri, M. M., The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997. 120: 1461-1483.
21. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M. et al., Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000. 192: 393-404.
22. + T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002. 125: 538-550.
23. + T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc. Natl. Acad. Sci. USA 2004. 101: 2428-2433.
24. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlen, C. and Goverman, J., A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 2001. 194: 669-676.
25. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000. 12: 431-440.
26. + regulatory T cells. J. Immunol. 2003. 171: 3348-3352.
27. Taylor, P. A., Lees, C. J., Fournier, S., Allison, J. P., Sharpe, A. H. and Blazar, B. R., B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 2004. 172: 34-39.
28. Paust, S., Lu, L., McCarty, N. and Cantor, H., Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 2004. 101: 10398-10403.
29. Schweitzer, A. N. and Sharpe, A. H., Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4. J. Immunol. 1999. 163: 4819-4825.
30. Begolka, W. S., Vanderlugt, C. L., Rahbe, S. M. and Miller, S. D., Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 1998. 161: 4437-4446.
31. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
32. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
33. Chen, Y., Langrish, C. L., McKenzie, B., Joyce-Shaikh, B., Stumhofer, J. S., McClanahan, T., Blumenschein, W. et al., Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 2006. 116: 1317-1326.
34. Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K. and Iwakura, Y., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566-573.
35. Rohn, T. A., Jennings, G. T., Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M. and Bachmann, M. F., Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol. 2006. 36: 2857-2867.
36. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. and Fathman, C. G., Mice with a disrupted IFN-garnma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 5-7.
37. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced aumimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
38. Goverman, J., Woods, A., Larson, L., Weiner, L. P., Hood, L. and Zaller, D. M., Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993. 72: 551-560.
39. Racke, M. K., Bonomo, A., Scott, D. E., Cannella, B., Levine, A., Raine, C. S., Shevach, E. M. and Rocken, M., Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 1994. 180: 1961-1966.